Finne P - Search Results

1

Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine.

Lempinen M, Kylänpää-Bäck ML, Stenman UH, Puolakkainen P, Haapiainen R, Finne P, Korvuo A, Kemppainen E. Lempinen M, et al. Among authors: finne p. Clin Chem. 2001 Dec;47(12):2103-7. Clin Chem. 2001. PMID: 11719473

2

Characterization and immunological determination of the complex between prostate-specific antigen and alpha2-macroglobulin.

Zhang WM, Finne P, Leinonen J, Vesalainen S, Nordling S, Rannikko S, Stenman UH. Zhang WM, et al. Among authors: finne p. Clin Chem. 1998 Dec;44(12):2471-9. Clin Chem. 1998. PMID: 9836714

3

Prostate-specific antigen.

Stenman UH, Leinonen J, Zhang WM, Finne P. Stenman UH, et al. Among authors: finne p. Semin Cancer Biol. 1999 Apr;9(2):83-93. doi: 10.1006/scbi.1998.0086. Semin Cancer Biol. 1999. PMID: 10202130 Review.

4

Measurement of the complex between prostate-specific antigen and alpha1-protease inhibitor in serum.

Zhang WM, Finne P, Leinonen J, Vesalainen S, Nordling S, Stenman UH. Zhang WM, et al. Among authors: finne p. Clin Chem. 1999 Jun;45(6 Pt 1):814-21. Clin Chem. 1999. PMID: 10351990 Clinical Trial.

5

Accurate determination of relative messenger RNA levels by RT-PCR.

Stenman J, Finne P, Ståhls A, Grénman R, Stenman UH, Palotie A, Orpana A. Stenman J, et al. Among authors: finne p. Nat Biotechnol. 1999 Jul;17(7):720-2. doi: 10.1038/10942. Nat Biotechnol. 1999. PMID: 10409357 No abstract available.

6

Concentration of free hCGbeta subunit in serum as a prognostic marker for squamous-cell carcinoma of the oral cavity and oropharynx.

Hedström J, Grenman R, Ramsay H, Finne P, Lundin J, Haglund C, Alfthan H, Stenman UH. Hedström J, et al. Among authors: finne p. Int J Cancer. 1999 Oct 22;84(5):525-8. doi: 10.1002/(sici)1097-0215(19991022)84:5<525::aid-ijc14>3.0.co;2-q. Int J Cancer. 1999. PMID: 10502732

7

Determination of prostate-specific antigen complexed to alpha(2)-macroglobulin in serum increases the specificity of free to total PSA for prostate cancer.

Zhang WM, Finne P, Leinonen J, Salo J, Stenman UH. Zhang WM, et al. Among authors: finne p. Urology. 2000 Aug 1;56(2):267-72. doi: 10.1016/s0090-4295(00)00609-9. Urology. 2000. PMID: 10925092

8

Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen.

Finne P, Auvinen A, Koistinen H, Zhang WM, Määttänen L, Rannikko S, Tammela T, Seppälä M, Hakama M, Stenman UH. Finne P, et al. J Clin Endocrinol Metab. 2000 Aug;85(8):2744-7. doi: 10.1210/jcem.85.8.6725. J Clin Endocrinol Metab. 2000. PMID: 10946875 Clinical Trial.

9

Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network.

Finne P, Finne R, Auvinen A, Juusela H, Aro J, Määttänen L, Hakama M, Rannikko S, Tammela TL, Stenman U. Finne P, et al. Among authors: finne r. Urology. 2000 Sep 1;56(3):418-22. doi: 10.1016/s0090-4295(00)00672-5. Urology. 2000. PMID: 10962306 Clinical Trial.

10

Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer.

Finne P, Zhang WM, Auvinen A, Leinonen J, Määttänen L, Rannikko S, Tammela TL, Stenman UH. Finne P, et al. J Urol. 2000 Dec;164(6):1956-60. J Urol. 2000. PMID: 11061890

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters